C2N Diagnostics announced three new hires this week: Timothy Veenestra as senior vice president of diagnostic services and innovation; Philip Verghese as principal scientist; and Phillip Herrbrich as laboratory manager.
Veenestra was previously director of the laboratory of proteomics and analytical technologies at the National Cancer Institute.
Verghese was a post-doctoral researcher in the laboratory of C2N scientific founder, Washington University researcher David Holtzman.
Herrbrich brings experience from working within GLP and CLIA-regulated laboratory environments, including at Mid-America Transplant Services, Barnes-Jewish Hospital, and the Washington University School of Medicine.